Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Bleeker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Histochemica|September 16, 2000
Direct comparison of the sensitivity of enzyme histochemical and immunohistochemical methods: cathepsin B expression in human colorectal mucosaF E Bleeker, L G Hazen, A Köhler, et al.
The British Journal of Dermatology|March 16, 2018
Cumulative risk of skin tumours in patients with Lynch syndromeF Adan, M B Crijns, W S E Zandstra, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 14, 2006
[Subtle skin lesions in the midline as an indication of a neurodermal closing defect]F E Bleeker, W R van Furth, C M A M van der Horst, et al.
The British Journal of Dermatology|April 8, 2021
Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome-associated tumoursB L M Ykema, F Adan, M B Crijns, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 16, 2000
Comparative localization of cathepsin B protein and activity in colorectal cancerL G Hazen, F E Bleeker, B Lauritzen, et al.
Clinical Neurology and Neurosurgery|May 22, 2021
Distal muscle weakness and optic atrophy without central nervous system involvement in a patient with a homozygous missense mutation in the C19ORF12-geneR J de Vries, B Jaeger, D M E I Hellebrekers, et al.
Oncogene|May 28, 2008
AKT1(E17K) in human solid tumoursF E Bleeker, L Felicioni, F Buttitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancerL Barault, A Amatu, F E Bleeker, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Histochemica|September 16, 2000
Direct comparison of the sensitivity of enzyme histochemical and immunohistochemical methods: cathepsin B expression in human colorectal mucosaF E Bleeker, L G Hazen, A Köhler, et al.
The British Journal of Dermatology|March 16, 2018
Cumulative risk of skin tumours in patients with Lynch syndromeF Adan, M B Crijns, W S E Zandstra, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 14, 2006
[Subtle skin lesions in the midline as an indication of a neurodermal closing defect]F E Bleeker, W R van Furth, C M A M van der Horst, et al.
The British Journal of Dermatology|April 8, 2021
Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome-associated tumoursB L M Ykema, F Adan, M B Crijns, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 16, 2000
Comparative localization of cathepsin B protein and activity in colorectal cancerL G Hazen, F E Bleeker, B Lauritzen, et al.
Clinical Neurology and Neurosurgery|May 22, 2021
Distal muscle weakness and optic atrophy without central nervous system involvement in a patient with a homozygous missense mutation in the C19ORF12-geneR J de Vries, B Jaeger, D M E I Hellebrekers, et al.
Oncogene|May 28, 2008
AKT1(E17K) in human solid tumoursF E Bleeker, L Felicioni, F Buttitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancerL Barault, A Amatu, F E Bleeker, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Pageof 1